The study of VSV-EBOV hopes to enroll 6,000 health and other frontline workers.
Officials said the center is clearly needed, for Ebola and other disease threats.
Though the global risk has dropped, Ebola is still a cause for concern, the WHO says.
The 30 new cases are the lowest since May 2014, fueled by improving response indicators.
Two possible next-generation Ebola vaccines fully protected monkeys with one dose.
There was evidence of Ebola virus in Liberia decades ago, according to a New York Times op-ed piece.
A 9-month boy tested positive for Ebola after he died in Sierra Leone's Kailahun district, a former hot spot for the disease that had not seen a case over the past 4 months, Reuters reported today.
A stray donkey that crossed from Mexico into Texas has tested positive for glanders, a highly contagious disease that primarily affects equines, the Southwest Farm Press reported this week.
Even hospitals that had done preparedness drills faced challenges, and the threat consumed a lot of resources.
The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.
